Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 3/20 | 0.53 |
| ▸ | MMP1 | P03956 | 3/20 | 0.51 |
| ▸ | MMP8 | P22894 | 2/20 | 0.51 |
| ▸ | ELOVL6 | Q9H5J4 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 2/20 | 0.43 |
| ▸ | MMP7 | P09237 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7510882 | 0.87 | MMP1 (0.57) | MMP13MMP1MMP8ADAM17MMP2 | |
| SCHEMBL7504807 | 0.86 | MAPT (0.44) | MMP13MMP1MMP8ELOVL6ADAM17 | |
| SCHEMBL7552475 | 0.85 | ALDH1A1 (0.53) | MMP13MMP1MMP8PKMKMT2A | |
| SCHEMBL7510655 | 0.85 | L3MBTL1 (0.49) | MMP13MMP1MMP8ADAM17TSHR | |
| SCHEMBL7508761 | 0.84 | MMP13 (0.50) | MMP13MMP1MMP8ELOVL6PKM | |
| SCHEMBL7505801 | 0.84 | MMP13 (0.50) | MMP13MMP1MMP8ELOVL6PKM | |
| Hydroxyamine SCHEMBL7577165 | 0.84 | MAPT (0.43) | MMP13MMP1MMP8ELOVL6ADAM17 | |
| SCHEMBL7555596 | 0.84 | MMP13 (0.47) | MMP13MMP1MMP8ELOVL6MEN1 | |
| SCHEMBL7553070 | 0.83 | MMP13 (0.46) | MMP13MMP1MMP8ELOVL6PKM | |
| SCHEMBL7508164 | 0.82 | ALDH1A1 (0.51) | MMP13MMP1MMP8ELOVL6MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020006922-A1 | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors | AMERICAN CYANAMID COMPANY (US) | 2002-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006922-A1 | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors | MMP12, ADAM33, MMP2 | MMP13 15/4885MMP1 7/4885MMP8 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.